Crescita Therapeutics Stock Market Value
| CTX Stock | CAD 0.47 0.02 4.08% |
| Symbol | Crescita |
Crescita Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Crescita Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Crescita Therapeutics.
| 04/21/2025 |
| 07/20/2025 |
If you would invest 0.00 in Crescita Therapeutics on April 21, 2025 and sell it all today you would earn a total of 0.00 from holding Crescita Therapeutics or generate 0.0% return on investment in Crescita Therapeutics over 90 days. Crescita Therapeutics is related to or competes with Micron Technology,, Westshore Terminals, Western Investment, Cogeco Communications, and Constellation Software. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug pro... More
Crescita Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Crescita Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Crescita Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.15) | |||
| Maximum Drawdown | 18.85 | |||
| Value At Risk | (4.08) | |||
| Potential Upside | 4.0 |
Crescita Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Crescita Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Crescita Therapeutics' standard deviation. In reality, there are many statistical measures that can use Crescita Therapeutics historical prices to predict the future Crescita Therapeutics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.61) | |||
| Treynor Ratio | (0.70) |
Crescita Therapeutics Backtested Returns
Crescita Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0925, which signifies that the company had a -0.0925 % return per unit of standard deviation over the last 3 months. Crescita Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Crescita Therapeutics' mean deviation of 1.42, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.36, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Crescita Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Crescita Therapeutics is expected to be smaller as well. At this point, Crescita Therapeutics has a negative expected return of -0.24%. Please make sure to confirm Crescita Therapeutics' information ratio and the relationship between the maximum drawdown and price action indicator , to decide if Crescita Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.25 |
Poor predictability
Crescita Therapeutics has poor predictability. Overlapping area represents the amount of predictability between Crescita Therapeutics time series from 21st of April 2025 to 5th of June 2025 and 5th of June 2025 to 20th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Crescita Therapeutics price movement. The serial correlation of 0.25 indicates that over 25.0% of current Crescita Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | 0.1 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Crescita Therapeutics lagged returns against current returns
Autocorrelation, which is Crescita Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Crescita Therapeutics' stock expected returns. We can calculate the autocorrelation of Crescita Therapeutics returns to help us make a trade decision. For example, suppose you find that Crescita Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Crescita Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Crescita Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Crescita Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Crescita Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Crescita Therapeutics Lagged Returns
When evaluating Crescita Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Crescita Therapeutics stock have on its future price. Crescita Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Crescita Therapeutics autocorrelation shows the relationship between Crescita Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Crescita Therapeutics.
Regressed Prices |
| Timeline |
Pair Trading with Crescita Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescita Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Crescita Stock
| 0.78 | NVDA | NVIDIA CDR | PairCorr |
| 0.75 | MU | Micron Technology, | PairCorr |
| 0.72 | MSFT | Microsoft Corp CDR | PairCorr |
| 0.69 | GOOG | Alphabet CDR Earnings Call Tomorrow | PairCorr |
| 0.68 | AUAU | Allegiant Gold Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to Crescita Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescita Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescita Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescita Therapeutics to buy it.
The correlation of Crescita Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescita Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescita Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crescita Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Crescita Stock
Crescita Therapeutics financial ratios help investors to determine whether Crescita Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.